Context· weakCOV-E009
The 2021 joint study's pathway ratings, and China's unaudited animal-testing account
- what the source states
- The joint study rated an intermediate-host pathway "likely to very likely" and a laboratory incident "extremely unlikely," and recorded China's account of extensive animal testing with no positive results.
- what we infer
- Included for provenance rather than for its ratings, which later WHO reviews superseded: the 2022 preliminary report reopened the laboratory hypothesis and the 2025 assessment states it could not be evaluated at all. Citing the 2021 rating as WHO's current position is an error both of this case's research briefs specifically warn against, and it remains common in public argument.
- limitations
- Conducted jointly with the government whose data access was in question, on terms the study itself records.
- Its animal-testing figures are the custodian's own account and have never been independently audited.
- Superseded on the laboratory question by the 2022 and 2025 reviews.